Candidates / 4212

Sekisui Jushi Corporation4212・Chemicals

Activist stake: Dalton / NAVF. Of the listed companies with this trait in 2021–22, 1 in 5 was bought in the following four years or so — against 1 in 11 for all listed companies.

Taking every trait together, its score is 1.6x the average — #667 of 3,751. The closest type of deal is strategic buyer.

Score1.6xvs average; #667 of 3,751
Past, similar score1 in 5were bought (19%)
Closest typeStrategic
Price-to-book0.89xmarket value ¥88.0bn

Why it looks like past targets

Score by type of buyer

Typevs average for the type
Buyout by the parent0.4x
Management buyout0.5x
Private equity2.3x
Strategic buyer2.4x

Ownership

Top 10 shareholders

HolderTypeStake
日本マスタートラスト信託銀行株式会社(投資信託口)Custodian/nominee6.4%
日本マスタートラスト信託銀行株式会社(その他信託口)Custodian/nominee5.7%
積水化学工業株式会社Company5.1%
NIPPON ACTIVE VALUE FUND PLCActivist5.0%
株式会社日本カストディ銀行(投資信託口)Custodian/nominee4.4%
積水ハウス株式会社Company3.3%
第一生命保険株式会社Financial institution2.7%
積水化成品工業株式会社Company2.7%
STATE STREET BANK AND TRUST COMPANY505001Custodian/nominee2.6%
樹栄会持株会Employee/partner plan2.6%

From the annual report for the year to 2026-03-31. Holder types are assigned by name and can be wrong (for example, a founder’s company can look like an operating company). Annual report (PDF, EDINET)

Key figures

Controlling shareholder (over 50%)
Yes
Largest corporate holder
5.1%
Founder family (individuals and their companies)
0.0%
Officers
0.5%
Net cash ÷ market value
18%
ROE
4.1%
Equity ratio
70%

Activist filings

Estimated cost = total acquisition funds ÷ shares held, from the latest report (or the previous one if the latest does not state the funds). Trades after the report's base date are not included. Stakes whose reports give no funding figure are left out. Share splits after the report are adjusted using the change in shares outstanding. Costs outside the stock's price range while held (0.8x the monthly low to 1.2x the high) are treated as reporting quirks (e.g. funds not updated after selling) and not shown. Stakes cut below 5% (mostly sold) are left out of the totals.

This site ranks listed companies by how closely their public filings (annual reports and large-shareholding reports) resemble past tender-offer and MBO targets. It is not a prediction that any company will be bought, is not based on any non-public information, and is not a recommendation to buy or sell. Not investment advice.

Updated 29 Sep 2026 00:48 JST